🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lifecore Biomedical, Inc.

LFCR Healthcare
$5.02 +$0.08 (1.62%)
Market Cap: $188.14 M
Gurus Holding
4
Popularity Rank
#2406
% of Shares Held
0.40%
Net Activity (Q4 2025)
+$151,575.15

Guru Ownership Trend

Guru Analysis for Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical, Inc. (LFCR), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $743,597.54.

Top institutional holders include Mario Gabelli and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $151,575.15 net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Mario Gabelli reduced exposure by 0.8%.

Key Holders

Top 5 by Value

$685,484
$132,278
$128,066
$120,900

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$157,301.15
Total Buy Value
New Buys 1
Additions 1
-$5,726
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Lifecore Biomedical, Inc. (LFCR)

Major holders include Mario Gabelli ($685,484), Cliff Asness ($132,278), Steven Cohen ($128,066). According to the latest reported data, 4 tracked investment managers collectively hold approximately 148,127 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $151,575.15, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited LFCR. The total reported sell value was $5,726.

Yes, 1 managers opened new positions in LFCR, and 1 increased their existing holdings. The total reported buy value was $157,301.15.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -0.8% 83,800 $685,484 Q4 2025
0.00% Add 28.4% 16,171 $132,278 Q4 2025
0.00% New Buy 15,656 $128,066 Q4 2025
0.00% New Buy 32,500 $120,900 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form